Roche’s Parkinson’s drug misses main goal in mid-stage trial
Investing.com — Roche’s experimental Parkinson’s disease drug, prasinezumab, failed to meet its primary objective in a mid-stage trial. The Swiss pharmaceutical giant
Investing.com — Roche’s experimental Parkinson’s disease drug, prasinezumab, failed to meet its primary objective in a mid-stage trial. The Swiss pharmaceutical giant
Investing.com – Cintas (NASDAQ: CTAS) reported fourth quarter EPS of $1.09, $0.08 better than the analyst estimate of $1.01. Revenue for the
Investing.com — Palantir Technologies Inc . (NASDAQ:PLTR) stock climbed 3% following a new coverage initiation by UBS and news of an
Investing.com — The Swedish krona has seen a slight increase following a decision by the Riksbank, Sweden’s central bank, to cut its
Investing.com — The sterling trimmed its gains against the dollar and fell against the euro after the Bank of England (BOE) decided
Investing.com — The European Central Bank (ECB) should maintain a strategy of implementing small, gradual interest rate cuts, according to Cypriot policymaker
Investing.com — The Federal Reserve reduced its benchmark interest rate by 25 basis points on Wednesday, marking the third consecutive cut but
MOSCOW (Reuters) – Following are some of the key quotes from Russian President Vladimir Putin’s annual phone-in and news conference. ON TRUMP Well, first
By Balazs Koranyi FRANKFURT (Reuters) – The European Central Bank should keep cutting interest rates by small increments and there is no need
By Gleb Bryanski and Vladimir Soldatkin MOSCOW (Reuters) – The Russian economy is showing signs of overheating which is stoking worryingly high inflation,